| 212097 | NDA | XERIS | | 003 | GVOKE HYPOPEN | SOLUTION;SUBCUTANEOUS | 0.5MG/0.1ML (0.5MG/0.1ML) | GLUCAGON | 2019-09-10 | Prescription | Yes |
| 004 | GVOKE HYPOPEN | SOLUTION;SUBCUTANEOUS | 1MG/0.2ML (1MG/0.2ML) | GLUCAGON | 2019-09-10 | Prescription | Yes |
| 005 | GVOKE KIT | SOLUTION;SUBCUTANEOUS | 1MG/0.2ML (1MG/0.2ML) | GLUCAGON | 2019-09-10 | Prescription | Yes |
| 001 | GVOKE PFS | SOLUTION;SUBCUTANEOUS | 0.5MG/0.1ML (0.5MG/0.1ML) | GLUCAGON | 2019-09-10 | Discontinued | No |
| 002 | GVOKE PFS | SOLUTION;SUBCUTANEOUS | 1MG/0.2ML (1MG/0.2ML) | GLUCAGON | 2019-09-10 | Prescription | Yes |
| 006 | GVOKE VIALDX | SOLUTION;INTRAVENOUS | 1MG/0.2ML (1MG/0.2ML) | GLUCAGON | 2019-09-10 | Prescription | Yes |
| 011366 | NDA | XERIS | | 001 | DARANIDE | TABLET;ORAL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | DICHLORPHENAMIDE | 1958-07-22 | Discontinued | No |
| 002 | KEVEYIS | TABLET;ORAL | 50MG | DICHLORPHENAMIDE | 1958-07-22 | Prescription | Yes |